A study performed at the University of São Paulo’s Biomedical Science Institute (ICB-USP) in Brazil shows that sofosbuvir, a drug used to treat chronic hepatitis C, is capable of eliminating... Read more
Short treatment with sofosbuvir and ledipasvir over only 6 weeks is sufficient to cure acute hepatitis C (HCV) A pilot study presented today found that all patients with acute HCV who were t... Read more